High-cost novel therapies challenge payers and patients, while biosimilars help balance affordability.
Andy Szczotka, PharmD
Advertisement
Articles by Andy Szczotka, PharmD
Advertisement
Latest Updated Articles
Navigating the Rapid Growth of Specialty Drugs: Opportunities, Challenges, and the Path AheadPublished: September 2nd 2024 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Announces Recall 580,000 Bottles of Prazosin Over Potential Carcinogenic Impurity
2
From Type 1 to Type 2 and Beyond: Navigating the Landscape of Diabetes
3
COVID-19 Reinfection Heightens Risk of Postacute Sequelae of SARS-CoV-2 in Pediatrics
4
Doxecitine–Doxribtimine Becomes First Approved Treatment for Rare Genetic Disorder
5
